Karen Sims
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Karen Sims
The proxy statement of Arbutus Biopharma Corp reports total compensation of $1,697,375 for Karen Sims in fiscal 2024, including a base salary of $490,000. Disclosed compensation is on record for 2 fiscal years. Karen Sims has spoken on 1 earnings call across 1 company, most recently for Arbutus Biopharma Corp on August 3, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Arbutus Biopharma Corp (ABUS)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arbutus Biopharma Corp
Other people whose current roles at this company are on record from its filings.
- Lindsay Androski CEO, Chairman, Board Member
- Mark J. Murray CEO
- Michael J. McElhaugh CEO, COO, Board Member
- Tuan Nguyen CFO
- Michael McElhaugh COO
- Mike McElhaugh COO
- J. Christopher Naftzger General Counsel
- Anuj Hasija Board Member
- Eric Venker, M.D., Pharm.D. Board Member
- Frank Torti, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Arbutus Biopharma Corp (ABUS) | M.D., Ph.D. Former Chief Medical Officer | $490,000 | $1,697,375 |
| 2023 | Arbutus Biopharma Corp (ABUS) | M.D., Ph.D. Former Chief Medical Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.